MRTX0902
MRTX0902 is an orally active and potent SOS1 inhibitor with an IC50 of 46 nM (WO2021127429A1; Example 12-10) [1].
Product Specifications
CAS Number
2654743-22-1
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Ras; SOS1
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mrtx0902.html
Purity
99.75
Solubility
DMSO : 12.5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
C[C@H](C1=C(C(C#N)=CC=C1)C)NC2=NN=C(C)C3=C2C=C(N4CCOCC4)N=C3
Molecular Formula
C22H24N6O
Molecular Weight
388.47
Precautions
H302, H315, H319
References & Citations
[1]Ketcham JM, et al. Design and Discovery of MRTX0902, a Potent, Selective, Brain-Penetrant, and Orally Bioavailable Inhibitor of the SOS1:KRAS Protein-Protein Interaction. J Med Chem. 2022 Jul 28;65 (14) :9678-9690.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
K-Ras
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15316104 1 Vial
Lentiviral human RYR1 shRNA (UAS) - Lentiviral human RYR1 shRNA (UAS, GFP) (100)
Sign In for Pricing
View Details 
585382 20 µg
Metallothionein-3, Recombinant, Mouse, aa1-68, His-Tag
Sign In for Pricing
View Details